Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy (vol 27, pg 680, 2021)

被引：2
|
作者：
Sun, Jingwei
Lu, Qiao
Sanmamed, Miguel F.
Wang, Jun
机构：
来源：
CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 13期
关键词：
D O I：
10.1158/1078-0432.CCR-21-1637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3804 / 3804
页数：1
相关论文
共 40 条
  • [1] Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy
    Sun, Jingwei
    Lu, Qiao
    Sanmanmed, Miguel F.
    Wang, Jun
    CLINICAL CANCER RESEARCH, 2021, 27 (03) : 680 - 688
  • [2] Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
    Wang, Jun
    Sun, Jingwei
    Liu, Linda N.
    Flies, Dallas B.
    Nie, Xinxin
    Toki, Maria
    Zhang, Jianping
    Song, Chang
    Zarr, Melissa
    Zhou, Xu
    Han, Xue
    Archer, Kristina A.
    O'Neill, Thomas
    Herbst, Roy S.
    Boto, Agedi N.
    Sanmamed, Miguel F.
    Langermann, Solomon
    Rimm, David L.
    Chen, Lieping
    NATURE MEDICINE, 2019, 25 (04) : 656 - +
  • [3] Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
    Jun Wang
    Jingwei Sun
    Linda N. Liu
    Dallas B. Flies
    Xinxin Nie
    Maria Toki
    Jianping Zhang
    Chang Song
    Melissa Zarr
    Xu Zhou
    Xue Han
    Kristina A. Archer
    Thomas O’Neill
    Roy S. Herbst
    Agedi N. Boto
    Miguel F. Sanmamed
    Solomon Langermann
    David L. Rimm
    Lieping Chen
    Nature Medicine, 2019, 25 : 656 - 666
  • [4] Next-generation cancer vaccines and emerging immunotherapy combinations
    Brandenburg, Anne
    Heine, Annkristin
    Brossart, Peter
    TRENDS IN CANCER, 2024, 10 (08) : 749 - 769
  • [5] Siglec-15 Is an Immune Suppressor and Potential Target for Immunotherapy in the Pre-Metastatic Lymph Node of Colorectal Cancer
    Du, Hang
    Tang, Jingling
    Li, Xiaoyun
    Wang, Xinjun
    Wu, Liyun
    Zhang, Ruyi
    Hu, Pingsheng
    Yang, Yuan
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [6] Emergomyces orientalis Emergomycosis Diagnosed by Metagenomic Next-Generation Sequencing (vol 27, pg 2740, 2021)
    He, Da
    Quan, Min
    Zhong, Hongyan
    Chen, Zhixing
    Wang, Xiaohui
    He, Fang
    Qu, Junyan
    Zhou, Taoyou
    Lv, Xiaoju
    Zong, Zhiyong
    EMERGING INFECTIOUS DISEASES, 2021, 27 (12) : 3205 - 3205
  • [7] Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6
    Klepsch, Victoria
    Siegmund, Kerstin
    Baier, Gottfried
    CANCERS, 2021, 13 (11)
  • [8] Application of next-generation imaging in biochemically recurrent prostate cancer (vol <bold>27, pg </bold>202, 2024)
    Moul, Judd W.
    Shore, Neal D.
    Pienta, Kenneth J.
    Czernin, Johannes
    King, Martin T.
    Freedland, Stephen J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 358 - 358
  • [9] Tumor-Associated Tertiary Lymphoid Structures: A Cancer Biomarker and a Target for Next-generation Immunotherapy
    Dieu-Nosjean, Marie-Caroline
    TUMOR MICROENVIRONMENT: NOVEL CONCEPTS, 2021, 1329 : 51 - 68
  • [10] Target-enrichment strategies for next-generation sequencing (vol 7, pg 111, 2010)
    Mamanova, Lira
    Coffey, Alison J.
    Scott, Carol E.
    Kozarewa, Iwanka
    Turner, Emily H.
    Kumar, Akash
    Howard, Eleanor
    Shendure, Jay
    Turner, Daniel J.
    NATURE METHODS, 2010, 7 (06) : 479 - 479
1234